SSA
SANA icon

Schonfeld Strategic Advisors’s Sana Biotechnology SANA Stock Holding History

Schonfeld Strategic Advisors’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-55,842
Closed -$227K – 2624
2025
Q4 		$227K Buy
+55,842
New +$250K ﹤0.01% 1665
2024
Q3 		– Sell
-105,325
Closed -$575K – 2377
2024
Q2 		$575K Buy
+105,325
New +$839K ﹤0.01% 1431
2024
Q1 		– Sell
-177,000
Closed -$722K – 2363
2023
Q4 		$722K Buy
177,000
+150,164
+560% +$553K 0.01% 1156
2023
Q3 		$104K Buy
+26,836
New +$144K ﹤0.01% 1492
2022
Q4 		– Sell
-134,854
Closed -$809K – 2959
2022
Q3 		$809K Buy
134,854
+117,454
+675% +$848K 0.01% 1426
2022
Q2 		$112K Sell
17,400
-64,000
-79% -$408K ﹤0.01% 2103
2022
Q1 		$672K Buy
+81,400
New +$658K 0.01% 1197

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Marex Group London $9.64B AUM 31.44% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $1.89B AUM 112.84% 1-Year Est. Return